Viewing Study NCT00255034

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:24 AM

Ignite Modification Date: 2026-03-01 @ 4:46 PM

Study NCT ID: NCT00255034

Status: TERMINATED

Last Update Posted: 2017-04-06

First Post: 2005-11-15

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Sponsor: Merck Sharp & Dohme LLC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Adverse Events Module Baseline Characteristics Module Participant Flow Module